SE451944B - Sett att framstella en dihydroergotamin-beredningsform med hog resorption - Google Patents

Sett att framstella en dihydroergotamin-beredningsform med hog resorption

Info

Publication number
SE451944B
SE451944B SE7712693A SE7712693A SE451944B SE 451944 B SE451944 B SE 451944B SE 7712693 A SE7712693 A SE 7712693A SE 7712693 A SE7712693 A SE 7712693A SE 451944 B SE451944 B SE 451944B
Authority
SE
Sweden
Prior art keywords
dihydroergotamine
water
nasal
compound
liquid
Prior art date
Application number
SE7712693A
Other languages
English (en)
Swedish (sv)
Other versions
SE7712693L (sv
Inventor
M Azria
T Cavanak
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE7712693L publication Critical patent/SE7712693L/
Publication of SE451944B publication Critical patent/SE451944B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01D—MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
    • G01D2207/00—Indexing scheme relating to details of indicating measuring values
    • G01D2207/10—Displays which are primarily used in aircraft or display aircraft-specific information

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE7712693A 1976-11-19 1977-11-10 Sett att framstella en dihydroergotamin-beredningsform med hog resorption SE451944B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1457576 1976-11-19
CH698977 1977-06-07

Publications (2)

Publication Number Publication Date
SE7712693L SE7712693L (sv) 1978-05-20
SE451944B true SE451944B (sv) 1987-11-09

Family

ID=25700540

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7712693A SE451944B (sv) 1976-11-19 1977-11-10 Sett att framstella en dihydroergotamin-beredningsform med hog resorption

Country Status (27)

Country Link
US (2) US4462983A (de)
JP (1) JPS5366440A (de)
AT (1) AT368881B (de)
AU (1) AU520754B2 (de)
CA (1) CA1103585A (de)
CS (2) CS228523B2 (de)
CY (1) CY1266A (de)
DE (2) DE2750090A1 (de)
DK (1) DK153440C (de)
ES (1) ES464275A1 (de)
FI (1) FI773376A (de)
FR (1) FR2371454A1 (de)
GB (1) GB1592563A (de)
GR (1) GR65229B (de)
HK (1) HK85984A (de)
HU (1) HU185924B (de)
IE (1) IE46167B1 (de)
IL (1) IL53419A (de)
KE (1) KE3453A (de)
MY (1) MY8400055A (de)
NL (1) NL187892C (de)
NO (1) NO773839L (de)
NZ (1) NZ185711A (de)
PH (1) PH23643A (de)
PT (1) PT67292B (de)
SE (1) SE451944B (de)
SG (1) SG61784G (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
US4284648A (en) * 1979-08-03 1981-08-18 The University Of Kentucky Research Foundation Nasal administration of propranolol
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
FI81258C (fi) * 1982-02-01 1990-10-10 Sandoz Ag Foerfarande foer framstaellning av en farmaceutisk komposition foer nasal administration.
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
GB8413795D0 (en) * 1984-05-30 1984-07-04 Sandoz Ltd Organic compounds
GB8426922D0 (en) * 1984-10-24 1984-11-28 Sandoz Ltd Galenic formulation
GB8501015D0 (en) * 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
FR2628638B1 (fr) * 1985-03-06 1992-12-18 Sandoz Lab Dispositif de pulverisation par voie nasale d'une dose unitaire de medicament en solution
JPS61263918A (ja) * 1985-05-16 1986-11-21 Banyu Pharmaceut Co Ltd 経皮吸収用製剤
AU587472B2 (en) * 1985-05-22 1989-08-17 Liposome Technology, Inc. Liposome inhalation method and system
CA1291036C (en) * 1986-04-23 1991-10-22 Edwin I. Stoltz Nasal administration of drugs
US4782047A (en) * 1986-05-22 1988-11-01 Syntex Pharmaceuticals International Ltd. Aqueous steroid formulations for nasal administration
US4897256A (en) * 1986-11-25 1990-01-30 Abbott Laboratories LHRH analog formulations
DE3710216A1 (de) * 1987-03-27 1988-10-06 Rentschler Arzneimittel Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen
DE68915203T2 (de) * 1988-03-22 1994-09-22 Fisons Plc, Ipswich, Suffolk Pharmazeutische Mischungen.
US4929640A (en) * 1988-04-04 1990-05-29 George D. McAdory Medicaments intended for combined use in the improvement of lymphocyte function
GB2237510B (en) * 1989-11-04 1993-09-15 Danbiosyst Uk Small particle drug compositions for nasal administration
IT1247472B (it) * 1991-05-31 1994-12-17 Fidia Spa Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
ES2177544T3 (es) * 1992-06-12 2002-12-16 Teijin Ltd Polvo ultrafinno para inhalar y metodo para su preparacion.
WO1993025193A1 (en) * 1992-06-12 1993-12-23 Teijin Limited Pharmaceutical preparation for intra-airway administration
ES2194867T3 (es) * 1993-03-26 2003-12-01 Franciscus Wilhelmus He Merkus Composiciones farmaceuticas para la administracion intranasal de apomorfina.
US5830853A (en) 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
US20010003739A1 (en) * 1993-06-24 2001-06-14 Astrazeneca Ab Systemic administration of a therapeutic preparation
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
US6794357B1 (en) 1993-06-24 2004-09-21 Astrazeneca Ab Compositions for inhalation
ES2197212T3 (es) * 1994-12-22 2004-01-01 Astrazeneca Ab Preparacion terapeutica para inhalacion que contiene la hormona paratiroidea, pth.
SE9404468D0 (sv) * 1994-12-22 1994-12-22 Astra Ab Powder formulations
EE9700138A (et) 1994-12-22 1997-12-15 Astra Aktiebolag Aerosoolravimvormid
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5955098A (en) * 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule
US7771746B2 (en) * 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
MXPA02007052A (es) * 2000-01-20 2002-12-13 Basilea Pharmaceutica Ag Composiciones que se administran nasalmente y que contienen peptidos ciclicos.
US20030008005A1 (en) * 2001-07-05 2003-01-09 R.T. Alamo Ventures, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
GB0208742D0 (en) * 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
GB2405334B (en) * 2002-04-17 2006-02-15 Nektar Therapeutics Uk Ltd Particulate materials
ES2691033T3 (es) 2007-02-11 2018-11-23 Map Pharmaceuticals Inc. Método de administración terapéutica de DHE para activar el alivio rápido de la migraña a la vez que se reduce al mínimo el perfil de los efectos secundarios
US20120000941A1 (en) * 2010-06-30 2012-01-05 Inspire Pharmaceuticals, Inc. Medicine dispenser
NZ741171A (en) 2015-09-10 2022-01-28 Impel Neuropharma Inc In-line nasal delivery device
EP3648738A1 (de) * 2017-07-02 2020-05-13 Dr. Reddy's Laboratories Limited Nasale darreichungsformen von dihydroergotamin
CN111936140A (zh) 2018-01-05 2020-11-13 英倍尔药业股份有限公司 通过精密鼻装置的双氢麦角胺的鼻内递送
EP3893877A4 (de) 2018-12-11 2022-09-14 Satsuma Pharmaceuticals, Inc. Zusammensetzungen, vorrichtungen und verfahren zur behandlung oder vorbeugung von kopfschmerzen
GB2581431A (en) * 2018-12-11 2020-08-19 Satsuma Pharmaceuticals Inc Compositions, devices, and methods for treating or preventing headaches

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1063512A (en) * 1962-11-30 1967-03-30 Benger Lab Ltd Aerosols
GB1175430A (en) * 1966-04-07 1969-12-23 Sandoz Ltd Pharmaceutical Compositions containing Ergot Alkaloids
CH507249A (de) * 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
CH534683A (de) * 1970-05-26 1973-03-15 Sandoz Ag Verfahren zur Herstellung neuer Mutterkornpeptidalkaloide
US4076715A (en) * 1972-09-26 1978-02-28 Sandoz Ltd. 13-Bromo lysergic acid compounds
CA990287A (en) * 1972-09-26 1976-06-01 Sandoz Patents Limited 13-bromo-lysergic acid compounds
NL7314066A (de) * 1972-10-18 1974-04-22
US3896228A (en) * 1973-03-15 1975-07-22 Sandoz Ltd Method for treating nephrises
US3883655A (en) * 1973-10-11 1975-05-13 Sandoz Ltd Ergocornine or 2-bromo-{60 -ergocyptine in the treatment of parkinsonism
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
EP0119493A1 (de) * 1983-03-16 1984-09-26 American Cyanamid Company Verwendung von Copolymeren der 2-Acrylamido-2-Methylpropan-Sulfonsäure zur Verbesserung des Zurückhaltevermögens und der Entwässerung in der Papierherstellung

Also Published As

Publication number Publication date
DE2802113A1 (de) 1979-07-26
JPS5366440A (en) 1978-06-13
AU3078377A (en) 1979-05-24
FR2371454B1 (de) 1980-08-22
ATA825477A (de) 1982-04-15
HU185924B (en) 1985-03-28
SG61784G (en) 1985-03-15
FI773376A (fi) 1978-05-20
US4758423A (en) 1988-07-19
IE46167B1 (en) 1983-03-09
ES464275A1 (es) 1978-12-16
NO773839L (no) 1978-05-22
IL53419A0 (en) 1978-01-31
FR2371454A1 (fr) 1978-06-16
US4462983A (en) 1984-07-31
PT67292B (fr) 1979-11-12
SE7712693L (sv) 1978-05-20
DK153440B (da) 1988-07-18
PH23643A (en) 1989-09-27
JPS6313965B2 (de) 1988-03-29
CS228523B2 (en) 1984-05-14
NL7712552A (nl) 1978-05-23
KE3453A (en) 1984-10-05
IL53419A (en) 1982-04-30
AU520754B2 (en) 1982-02-25
AT368881B (de) 1982-11-25
HK85984A (en) 1984-11-16
NL187892C (nl) 1992-02-17
CS228502B2 (en) 1984-04-16
PT67292A (fr) 1977-12-01
NL187892B (nl) 1991-09-16
DK499477A (da) 1978-05-20
DE2750090A1 (de) 1978-06-01
CA1103585A (en) 1981-06-23
GB1592563A (en) 1981-07-08
MY8400055A (en) 1984-12-31
DK153440C (da) 1989-01-02
IE46167L (en) 1978-05-19
GR65229B (en) 1980-07-30
NZ185711A (en) 1980-04-28
CY1266A (en) 1984-11-23

Similar Documents

Publication Publication Date Title
SE451944B (sv) Sett att framstella en dihydroergotamin-beredningsform med hog resorption
Grass et al. Mechanisms of corneal drug penetration I: in vivo and in vitro kinetics
EP1100465B1 (de) Medizinische aerosolformulierungen
ES2197990T3 (es) Aerosol bucal no-polar para nitroglicerina.
KR100217258B1 (ko) 경비조성물
US2868691A (en) Self-propelling compositions for inhalation therapy containing a salt of isoproterenol or epinephrine
EP1014943B1 (de) Medizinische aerosolformulierungen
DE3751811T2 (de) LH-RH-Analoga enthaltende Formulierungen
JPH07103043B2 (ja) カルシトニン組成物およびその用途
JPH11502837A (ja) ブチクソコートエアゾール製剤
Baluom et al. Absorption enhancement of calcitonin in the rat intestine by carbopol-containing submicron emulsions
JP2006501220A (ja) 薬剤の投与及び吸収促進方法
Bennett et al. Pulmonary delivery of detirelix by intratracheal instillation and aerosol inhalation in the briefly anesthetized dog
US20170340649A1 (en) Topical aqueous spray compositions of halobetasol
EP0511991B1 (de) Penciclovir enthaltende pharmazeutische formulierung
KR20120004981A (ko) 경비 전달용 펩티드 약제
Adjei et al. Effect of formulation adjuvants on gastrointestinal absorption of leuprolide acetate
US5093127A (en) Preparation of fr115224 substrate for parenteral administration
US20060165603A1 (en) Solubilisation of drugs in hfa propellant by means of emulsions
SE447961B (sv) Stabil, etomidathaltig infusionsvetska for intravenos administrering
Gao et al. Water-in-CO2 microemulsions with a simple fluorosurfactant
JP3498041B2 (ja) プラルモレリン含有点鼻用製剤
US20180028766A1 (en) Touch-free topical spray of halobetasol
CZ256592A3 (en) Pharmaceutical composition containing bradykinin antagonists for local use in nose and eye
KR820000110B1 (ko) 맥각 펩티드 알카로이드를 함유하는 약학적 조성물

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7712693-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7712693-6

Format of ref document f/p: F